Lisa Mayr
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI.
Journal: European journal of radiology
Published: May 01, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2026
Impact of Bevacizumab treatment intervals on surgical interventions in pediatric neuro-oncology.
Journal: Neuro-oncology advances
Published: August 27, 2025
Medulloblastoma: Current Standard of Care and Future Treatment Opportunities.
Journal: Paediatric drugs
Published: June 15, 2025
Identification of a Druggable Target That Predicts Postoperative Crohn's Disease Recurrence.
Journal: Gastroenterology
Published: May 01, 2025
Metabolic stress sensing by epithelial RXRα links westernization of diet with Crohn's disease.
Journal: Cell metabolism
Published: February 03, 2025
Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation.
Journal: Gastroenterology
Published: December 03, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Journal: Neuro-oncology
Published: November 18, 2024
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.
Journal: Acta neuropathologica
Published: October 07, 2024
Last Updated: 09/26/2026